BioNexus Gene Lab Corp (BGLC): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2025-08-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

-$0.09
Year ended 2024-12-31
2023-12-31: -$0.172024-12-31: -$0.09-$0.09
2023-12-31 EPS (Diluted) (USD per share) 2024-12-31
Period endedEPS (Diluted)Change YoYSource filing
2024-12-31-$0.09n/m2025-04-15, From 2024-01-01
2023-12-31-$0.17n/a2025-04-15, From 2023-01-01